Although the specific mechanisms are open to debate, raised PSA levels within the blood of men with PC are not due to amplified expression of the protein, but instead result from increased release of PSA into the blood due to the disruption of prostate architecture observed in prostate tumours [17]. The gene discussed is KLK3; the disease is pachyonychia congenita.